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Abstract: Cell migration is a crucial event for tissue organization during development, and 
its dysregulation leads to several diseases, including cancer. Cells exhibit various types of 
migration, such as single mesenchymal or amoeboid migration, collective migration and 
scaffold cell-dependent migration. The migration properties are partly dictated by cell adhesion 
and its endocytic regulation. While an epithelial-mesenchymal transition (EMT)-mediated 
mesenchymal  cell  migration  requires  the  endocytic  recycling  of  integrin-mediated 
adhesions  after  the  disruption  of  cell-cell  adhesions,  an  amoeboid  migration  is  not 
dependent  on  any  adhesions  to  extracellular  matrix  (ECM)  or  neighboring  cells.  
In contrast, a collective migration is mediated by both cell-cell and cell-ECM adhesions, 
and a scaffold cell-dependent migration is regulated by the endocytosis and recycling of 
cell-cell  adhesion  molecules.  Although  some  invasive  carcinoma  cells  exhibit  an  
EMT-mediated  mesenchymal  or  amoeboid  migration,  other  cancer  cells  are  known  to 
maintain cadherin-based cell-cell adhesions and epithelial morphology during metastasis. 
On the other hand, a scaffold cell-dependent migration is mainly utilized by migrating 
neurons in normal developing brains. This review will summarize the structures of cell 
adhesions, including adherens junctions and focal adhesions, and discuss the regulatory 
mechanisms for the dynamic behavior of cell adhesions by endocytic pathways in cell 
migration  in  physiological  and  pathological  conditions,  focusing  particularly  on  neural 
development and cancer metastasis. 
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1. Introduction 
Cell adhesion  is  essential for the organization and various biological  functions  of multicellular 
organisms. There are two major types of cell adhesions; cell-to-cell and cell-to-extracellular matrix 
(ECM), both of which consist of transmembrane cell adhesion molecules, intracellular scaffold or 
signaling proteins and cytoskeletons (Figure 1). Cadherin family cell adhesion molecules and their 
associated scaffold proteins, catenins, play important roles in the formation and functions of cell-cell 
adhesions, adherens junctions and desmosomes [1]. In contrast, the major transmembrane proteins at 
cell-ECM adhesions are integrin heterodimers [2]. These cell-cell and cell-ECM adhesion complexes 
are stabilized by actin cytoskeleton or intermediate filaments, but dynamically rearranged under some 
circumstances,  such  as  cell  migration  and  cancer  metastasis  [3,4].  In  the  initial  step  of  cancer 
metastasis, tumor cells sometimes undergo epithelial-mesenchymal transition (EMT), which requires 
the disruption of cell-cell adhesions. Subsequently, the mesenchymal cancer cells begin migration and 
invade into the basement membranes and surrounding stromal tissues. The migrating mesenchymal 
cells constantly form new adhesions to ECM at the cell front, whereas a portion of the cell-ECM 
adhesions are disrupted by endocytosis at the rear. In contrast, recent reports indicate that some cancer 
cells maintain cell-cell adhesions and epithelial morphology during metastasis. This type of migration, 
called a collective cell migration, requires both cell-cell and cell-ECM adhesions. Furthermore, other 
cancer cells migrate in the absence of formation of any adhesions to neighboring cells or ECMs (an 
amoeboid migration). Thus, cancer cells exhibit various types of migration, which can be classified 
according to the cell adhesion properties [5] (Figure 1). 
Figure 1. Classification of cell migration types. Orange dots: cell-ECM adhesions, Red 
rectangles: cell-cell adhesions, Black bars: ECMs. See Introduction. 
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Figure 1. Cont. 
  Cell-Cell adhesion  Cell-ECM adhesion 
Mesenchymal single cell migration  Not required  Essential 
Amoeboid single cell migration  Not required  Not required 
Collective cell migration  Essential  Essential 
Scaffold cell-dependent cell migration  Essential  Not or less required 
In addition to the various migration patterns of cancer cells, there is another type of migration, a 
scaffold cell-dependent migration, which only depends on cell-cell adhesions (Figure 1). This type of 
migration is  rarely observed in  cancer metastasis but occurs mainly in  normal  brain development. 
During the development of the cerebral cortex, immature neurons exhibit multi-step migration to form a 
functional brain [6]. The major migration mode of neurons is a radial glial cell-dependent migration, 
which is mediated by the endocytic recycling of cadherins, rather than integrins [7]. In this review,  
I  summarize  the  structures  of  cell  adhesions  and  their  dynamic  regulation  by  endocytosis  and 
membrane trafficking. I also introduce the physiological and pathological roles of the regulation of cell 
adhesions in various types of cell migration in neural development and cancer metastasis. 
2. Structures and Functions of Cell Adhesion Complexes 
2.1. Adherens Junctions 
Adherens  junctions  are  observed  in  many  cell  types,  including  epithelial  cells  and  fibroblasts 
(Figure 2a). The adherens junctions are required for the formation and maintenance of physical association 
of cells in a calcium-dependent manner [1]. Cadherin is a key molecule in calcium-dependent cell 
adhesion,  whereas  nectins  and  nectin-like  proteins,  which  are  calcium-independent  cell  adhesion 
molecules,  also  have  important  roles  in  adherens  junctions;  nectin  and  its  associated  intracellular 
molecule, afadin, initiate the formation of adherens junctions by the recruitment of a cadherin-catenin 
complex to the adherens junctions [8,9] (Figure 2b). While a cadherin superfamily consists of more than a 
hundred members, classic cadherins, including E-cadherin (cdh1) and N-cadherin (cdh2), comprise 
about 20 molecules. The extracellular domains of classic cadherins provide trans-homophilic binding 
to other cadherins on neighboring cells, and their intracellular domains directly interact with β-catenin 
and p120-catenin (p120
ctn) [1,10]. α-catenin binds both β-catenin and actin filaments (F-actin), suggesting 
that β- and α-catenins link cadherin with actin cytoskeleton. However, it has been reported that the  
α-catenin,  complexed  with  β-catenin  and  cadherin,  rarely  interacts  with  F-actin  [11,12].  α-catenin 
binds to several actin-binding proteins, such as vinculin and EPLIN, and EPLIN concurrently forms a 
complex  with  cadherin,  α-catenin,  β-catenin  and  F-actin,  suggesting  that  EPLIN  and  some  other  
actin-binding proteins regulate the interaction between cadherins and F-actin cooperatively with α- and 
β-catenins [13,14] (Figure 2b). Int. J. Mol. Sci. 2012, 13  4567 
 
 
Figure  2. Molecular structures of cell-cell and cell-ECM junctions. (a) Epithelial cells 
contain  both  cell-cell  junctions  (Tight  junctions,  Adherens  junctions,  Desmosomes  and 
Gap junctions) and cell-ECM junctions (Focal adhesions and Hemidesmosomes). While 
fibroblasts  form  cadherin-based  cell-cell  junctions,  a  major  adhesion  in  fibroblasts  is 
integrin-based  focal  adhesions.  Red  bars:  actin  filaments,  Purple  lines:  intermediate 
filaments, Orange dots in the lower panel: focal adhesions, Purple dots in the lower panel; 
focal  complex  (immature  focal  adhesion);  (b–e)  Molecular  components  of  adherens 
junctions (b), desmosomes (c), tight junctions (d) and focal adhesions (e). 
 
2.2. Desmosomes 
Desmosomes  are  patch-like  intercellular  junctions,  and  abundantly  observed  in  skin  and 
myocardium, both of which bear mechanical stress (Figure 2a). The desmosomes are composed of 
non-classic  cadherins,  desmogleins  and  desmocollins,  and  provide  a  strong  intercellular  
connection [15,16]. Desmoglein and desmocollin are directly or indirectly associated with plakoglobin, 
plakophilin,  desmoplakin  and  intermediate  filaments  (Figure  2c).  Four  and  three  isoforms  of 
desmogleins and desmocollins have been identified in humans, respectively. Mutations or abnormal 
expression of desmosomal proteins  are associated with several diseases, including arrhythmogenic 
right  ventricular  cardiomyopathy  (ARVC),  skin  diseases  and  cancer  [17–19].  Mutations  in  
desmoglein-2, desmocollin-2, desmoplakin and plakoglobin have been identified in ARVC patients, 
whereas  N-terminal  deletion  in  desmoglein-1  leads  to  striate  palmoplantar  keratoderma  [20,21].  
In addition,  desmogleins  are targets  of autoimmune diseases,  pemphigus  foliaceus  and pemphigus 
vulgaris [17,19,22]. Int. J. Mol. Sci. 2012, 13  4568 
 
 
2.3. Tight Junctions and Gap Junctions 
Tight junctions and gap junctions are cadherin-independent adhesions, although some crosstalk has 
been  reported  between  cadherins  and  the  components  of  tight  junctions  or  gap  junctions.  Tight 
junctions are located at the most apical part of the lateral membranes in epithelial and endothelial cells 
(Figure 2a). Two major roles of tight junctions are ―barrier‖ and ―fence‖ functions [23,24]. At the tight 
junction strands, composed of claudin family and occludin, the intercellular distance between two 
neighboring cells is nearly zero, so that the tight junction restricts paracellular diffusion of substances 
and ions. In addition to the selective paracellular barrier function, tight junctions separate the plasma 
membrane into apical and basolateral domains to confine the diffusion of transmembrane proteins and 
lipids to the specific membrane domain as a fence. Both claudins and occludin bind to intracellular 
PDZ  domain-containing  proteins,  ZO-1  (Figure  2d).  Junctional  adhesion  molecule  (JAM)  family 
proteins are also associated with ZO-1 and localized at tight junctions [25]. 
Gap junctions consist of homo- or hetero-hexamers of connexin (Cx) proteins, such as Cx43, Cx26 
and  Cx32.  Connexin  hexamers,  called  connexons,  form  intercellular  channels,  which  allow  the 
diffusion of small molecules and electrical signals [26]. Some connexins are reported to interact with 
ZO-1, and Cx43 can be co-immunoprecipitated with N-cadherin and its associated catenins, suggesting 
that there is crosstalk between gap junctions and other junctional complexes [26,27]. Furthermore, 
components  of  gap  junctions  and  tight  junctions  as  well  as  cadherin-based  adhesions  have  been 
associated with cancer [28–31]. 
2.4. Focal Adhesions 
In addition to these cell-cell adhesions, cells also attach to ECMs, such as fibronectin, laminin, 
collagen and vitronectin. A major receptor for ECM is integrins. In humans, 18 α and 8 β subunits 
form at least 24 α–β heterodimers of integrins [2,32–36] (Table 1). Integrin heterodimers are localized 
at focal adhesions or hemidesmosomes, which are F-actin- or intermediate filament-based cell-ECM 
adhesion sites, respectively (Figure 2a), although some integrins serve cell-cell adhesion (Table 1).  
It has been reported that many scaffold or signaling proteins, including talin, vinculin, zyxin, focal 
adhesion kinase (FAK), Src, paxillin and p130
cas, are localized at focal adhesions [37–39] (Figure 2e). 
Talin directly binds to β1-integrin and an actin-binding protein, vinculin. In addition to the role linking 
integrins and F-actin, talin is also required for integrin activation [40,41]. The binding of talin induces 
the switching of integrins from inactive to active conformations. Therefore, talin plays important roles 
in both an inside-out activation of integrin and outside-in signal for the maturation of focal adhesion.  
A recent report shows that SHARPIN perturbs the recruitment of talin to integrins and thereby inhibits 
the integrin activation  [42]. Vinculin exhibits  an intra-molecular interaction, which inactivates the 
scaffold function. In contrast, an active open form of vinculin interacts with many molecules, such as 
α-actinin, paxillin, vinexin and vasodilator-stimulated phosphoprotein (VASP) [43,44] (Figure  2e). 
While α-actinin, as well as vinculin, directly binds to F-actin, paxillin and vinexin interact with FAK 
and Sos, an activator for Ras, respectively [37,45,46]. FAK forms a complex with a Src kinase and 
Grb2, an adaptor protein that activates the Ras-MAP kinase pathway. Vinexin is reported to promote 
the  activation  of  c-jun  N-terminal  kinase  (JNK)  [47].  Thus,  focal  adhesions  function  as  not  only  a  Int. J. Mol. Sci. 2012, 13  4569 
 
 
cell-ECM  adhesion  but  also  a  signaling  center  to  regulate  cell  migration,  morphological  changes, 
survival and proliferation. 
Table 1. Integrin subunits and their ligands. 
Integrin subunits  Major Ligands 
α1  β1  Collagen, Laminin 
α2  β1  Collagen, Laminin, Tenascin,  
α3  β1  Laminin, Collagen 
α4  β1  Fibronectin, VCAM-1 
β7  MAdCAM-1, Fibronectin 
α5  β1  Fibronectin 
α6  β1  Laminin 
β4  Laminin 
α7  β1  Laminin 
α8  β1  Fibronectin, Tenascin 
α9  β1  Tenascin 
α10  β1  Collagen 
α11  β1  Collagen 
αIIb  β3  Fibronectin, Vitronectin, Fibrinogen 
αv  β1  Vitronectin, Fibronectin 
β3  Vitronectin, Fibronectin, Fibrinogen 
β5  Vitronectin 
β6  Fibronectin, Tenascin 
β8  Vitronectin 
αL  β2  ICAM-1, -2, -3 
αM  β2  Fibrinogen, iC3b 
αX  β2  Fibrinogen, iC3b 
αD  β2  ICAM-3, VCAM-1 
αE  β7  E-cadherin 
3. Intracellular Trafficking Pathways 
Membrane  trafficking  pathways  are  roughly  classified  according  to  their  origins;  secretory 
pathways  originated  from  ER-Golgi,  endocytic  pathways  from  plasma  membranes  and  autophagy 
pathways  from  cytoplasm  [48–52]  (Figure  3).  Newly  synthesized  cell  adhesion  molecules  are 
transported  into  the  plasma  membrane  via  secretory  pathways.  A  recent  report  shows  that  two 
desmosomal cadherins, desmoglein-2 and desmocollin-2, are transported by the use of different plus-end 
motor proteins, kinesin-1 and kinesin-2, respectively [53]. Furthermore, the endocytic recycling and 
tight junction targeting of claudin and occludin are dependent on Rab13, whereas the transport of  
E-cadherin  to  the  adherens  junctions  requires  Rab8  in  epithelial  cell  lines  [54,55].  Therefore,  the 
trafficking of cell adhesion molecules in distinct adhesion complex utilizes different transport machinery. 
Cell  adhesion  molecules,  engaged  in  adhesion  complexes,  are  relatively  stable,  but  they  also 
undergo  constant  or  stimuli-mediated  remodeling  by  endocytosis  and  the  recycling  system. 
Endocytosis  can  be  classified  into  several  types,  including  clathrin-mediated  endocytosis,  
caveolin-mediated endocytosis and macropinocytosis [56]. Endocytosis and its downstream endocytic Int. J. Mol. Sci. 2012, 13  4570 
 
 
pathways are mainly regulated by Rab family small GTPases [52,57–59] (Figure 3). Many types of 
endocytosis are mediated by the activities of dynamin, an atypical GTPase, and Rab5. Rab5 and its 
subfamily proteins, such as Rab21, Rab22 and Rab31, promote the internalization of transmembrane 
proteins  and  their  transport  into  early  endosomes.  As  early  endosomes  are  also  called  ―sorting 
endosomes‖, there are many trafficking pathways from early endosomes; recycling pathway to plasma 
membrane, degradation pathway to lysosomes and retrograde transport to trans-Golgi network (TGN) 
(Figure 3). Whereas direct and indirect recycling pathways require Rab4 and Rab11, respectively, the 
lysosomal degradation pathway is dependent on Rab7. In contrast, the retrograde transports from early 
and late endosomes are regulated by the retromer complex and Rab9, respectively. 
Figure  3.  Intracellular  trafficking  pathways.  Three  major  trafficking  pathways  are 
endocytic  pathways  (blue  arrows),  secretory  pathways  (green  arrows)  and  autophagy 
pathways (orange arrows). Some cargo molecules are transported from endosomes to trans-Golgi 
network via retrograde pathways. 
 
4. Cadherin Endocytosis and Epithelial-to-Mesenchymal Transition 
The cytoplasmic domain of E-cadherin contains a dileucine motif followed by a NVYYY motif at 
the membrane-proximal region and a β-catenin-binding site at the membrane-distal region (Figure 4). 
A dileucine motif is a binding site for clathrin adaptor complexes, such as AP-2, [60] and mutation in 
the dileucine motif in E-cadherin inhibits its endocytosis [61]. The dileucine motif in E-cadherin also 
binds to p120
ctn, which masks the dileucine motif to prevent the endocytosis of E-cadherin [62–64]. 
Knockdown of p120
ctn results in the internalization of cadherins and loss of cell-cell contacts. However, 
the binding of Numb, a cytoplasmic adaptor, to p120
ctn cancels the p120
ctn-mediated suppression of E-
cadherin  endocytosis,  because  Numb  recruits  an  AP-2  clathrin  adaptor  complex  [65].  Numb  also Int. J. Mol. Sci. 2012, 13  4571 
 
 
interacts  with  the NVYYY motif on E-cadherin, which may prevent  the binding of p120
ctn  to E-
cadherin [66]. Thus, Numb promotes E-cadherin endocytosis through two different mechanisms. 
Figure 4. Dileucine and NVYYY motifs in E-cadherin intracellular region. A dileucine 
motif (shown in red characters) binds to endocytic adaptor proteins, such as AP-2, whereas 
a NVYYY motif (shown in blue characters), including the tyrosine phosphorylation site by 
a Src kinase, are required for a strong binding to p120
ctn. A triple glycine (GGG) motif is 
also involved in the strong and static binding to p120
ctn. 
 
A recent structural and NMR study shows that the dileucine motif in E-cadherin serves a moderate 
and  dynamic  interaction  with  p120
ctn,  whereas  the  NVYYY  motif,  including  the  tyrosine 
phosphorylation site by a Src kinase, are required for a strong and static binding to p120
ctn [67].  
Src-mediated phosphorylation of the NVYYY motif on E-cadherin induces the dissociation of p120
ctn 
and recruits a c-Cbl-related E3 ubiquitin ligase, Hakai. Hakai induces the ubiquitination of E-cadherin 
and subsequently its endocytosis and degradation [68]. In addition, Src and receptor tyrosine kinases, 
such  as  epidermal  growth  factor  (EGF)  receptor  and  brain-derived  neurotrophic  factor  (BDNF) 
receptor, phosphorylate  Tyr654 on β-catenin,  resulting in  the disruption of the cadherin β-catenin 
complex.  In  contrast,  a  cytoplasmic  kinase,  Fer,  and  hepatocyte  growth  factor  (HGF)  receptor 
phosphorylate Tyr142 on β-catenin, leading to the perturbation of the interaction between β-catenin 
and α-catenin [69,70]. 
Increased tyrosine phosphorylation occurs in growth factor-treated cells or oncogenic environments. 
Various growth factors, such as transforming growth factor β(TGFβ), HGF, fibroblast growth factor 
(FGF) and EGF, and oncogenic v-Src are known to induce an epithelial-mesenchymal transition (EMT) 
[71–73].  EMT  progression  involves  the  reduction  in  cell-cell  adhesion,  apico-basal  polarity  and 
epithelial  markers, including E-cadherin, and the upregulation  of mesenchymal  markers, including  
N-cadherin, vimentin and α-smooth muscle actin. Although transcriptional regulation has crucial roles in 
the induction of EMT [74], the tyrosine phosphorylation of E-cadherin and catenins are also important 
events for EMT [75]. HGF treatment or v-Src expression activates Arf6, an Arf family small GTPase, 
which enhances E-cadherin endocytosis partly through the recruitment of Nm23-H1, an activator for 
dynamin [76,77]. HGF also induces Ras-mediated activation of RIN2, an activator for Rab5, increasing 
Rab5-dependent endocytosis of E-cadherin [78]. Int. J. Mol. Sci. 2012, 13  4572 
 
 
In addition to the clathrin-mediated endocytosis, caveolin-mediated endocytosis and macropinocytosis 
are involved in E-cadherin internalization [79,80]. EGF treatment promotes E-cadherin macropinocytosis 
into endosomes, in which E-cadherin still colocalizes with p120
ctn, in MCF-7 cells [81]. Interestingly, 
E-cadherin and N-cadherin enhance macropinocytosis [82], implicating the positive feedback loop. 
5. Integrin Endocytosis and Cell Migration 
Integrin  endocytosis  and  recycling  are  known  to  regulate  the  migration  of  many  cell  types, 
including neutrophils, fibroblasts and several cancer cell lines [83–85]. The endocytosis of integrins 
promotes the disassembly of focal adhesion and detachment from ECM at the rear of the cell, and 
thereby directs cell migration [86].  
β5-integrin, which forms a heterodimer only with αv-integrin as a vitronectin receptor (Table 1), is 
observed at clathrin-coated membrane domains in cultured myotubes [87]. Furthermore, Numb, an 
endocytic adaptor for clathrin-mediated endocytosis, binds to β1-integrin, but not intracellular focal 
adhesion components, such as talin, vinculin, paxillin and FAK, and enhances integrin endocytosis and 
cell migration on fibrocentin or collagen [88]. Dab2 and autosomal recessive hypercholesteremia (ARH), 
another  endocytic  adaptor  proteins,  are  also  involved  in  integrin  endocytosis  and  cell  
migration [89,90]. Suppression of Dab2 increases the cell surface levels of β1-, α1-, α2-, α3-, but not 
α5- or αv-integrins. Considering the binding specificity of integrins to ECM proteins (Table 1), Dab2 
prefers to control the endocytosis of receptors for collagen and laminin, rather than fibronectin and 
vitronectin. Interestingly, Dab2-mediated endocytosis occurs evenly over the cell surface, suggesting 
that Dab2 increases the intracellular integrin pool that is recycled to create new focal adhesions [89]. 
Rab family small GTPases and Arf6 are known to regulate integrin endocytosis and intracellular 
trafficking  [85,91].  Rab21  and  Rab5  are  co-immunoprecipitated  with  β1-integrin  and  control  its 
endosomal trafficking in MDA-MB-231 breast cancer cells [92]. Internalized integrins are recycled 
back to the plasma membrane through Rab4-dependent direct recycling pathway or Rab11-dependent 
indirect recycling pathway via recycling endosomes (Figure 3). While phosphatidylinositol 3-kinase 
(PI3K) and Akt regulate the trafficking of αvβ3- and α5β1-integrins from Rab11-positive recycling 
endosomes to the plasma membranes, platelet-derived growth factor (PDGF) treatment promotes the 
Rab4-dependent fast recycling of αvβ3-integrin from early endosomes without the involvement of 
Rab11 [93,94]. Interestingly, β1-integrin also enhances PDGF receptor trafficking and directed cell 
migration [95]. 
Whereas a major fibronectin receptor is α5β1-integrin (Table1), syndecan-4, a membrane-intercalated 
heparan sulfate proteoglycan, acts as a co-receptor for fibronectin [96]. A recent study shows that  
the  binding  of  fibronectin  to  syndecan-4  induces  α5β1-integrin  endocytosis  in  a  dynamin-  and 
caveolin-dependent manner [97]. Syndecan-4 is associated with protein kinase Cα (PKCα), and this 
interaction is required for RhoG-regulated α5β1-integrin endocytosis and cell migration during wound 
healing.  PKCα  is  also  reported  to  interact  with  β1-integrin  and  to  promote  its  endocytosis  [98].  
A portion of the internalized β1-integrin is recycled to the plasma membrane via PKCε activity, which 
promotes cell migration [99,100]. Thus, integrin trafficking, regulated by Rab family small GTPases 
and several kinases, has important roles in cell migration. Int. J. Mol. Sci. 2012, 13  4573 
 
 
Integrin endocytosis is also required for the internalization of ECM proteins, such as vitronectin and 
fibronectin.  In  human  skin  fibroblasts,  β5-integrin  and  vitronectin  are  co-localized  at  intracellular 
vesicles  and  transported  into  lysosomes  [101].  Another  report  shows  that  caveolin-mediated 
endocytosis  of  β1-integrin  is  involved  in  the  turnover  of  fibronectin  [102].  The  engagement  of 
fibronectin  causes  the  ubiquitination  of  α5-integrin,  which  is  transported  into  lysosomes  via  the 
ESCRT  pathway  [103].  Interestingly,  this  selective  sorting  and  degradation  of  fibronectin-bound  
α5β1-integrin is required for fibroblast migration [103]. 
Many reports have indicated that integrin trafficking is associated with cancer metastasis [91,104]. 
Increased  expression  of  αvβ6-integrin  is  found  in  many  cancers,  including  oral  carcinoma.  
HS1-associated protein X-1 (HAX-1) directly binds to the cytoplasmic domain of β6-integrin and this 
interaction enhances the migration and invasion of oral squamous cell carcinoma cell lines through 
promotion  of  the  clathrin-mediated  endocytosis  of  αvβ6-integrin  [105].  In  addition,  enhanced 
expression  of  Arf6  is  observed  in  breast  cancer  cells,  and  GEP100  (also  known  as  BRAG2),  an 
activator for Arf6, is responsible for the invasive activity of MDA-MB-231 breast cancer cells [106]. 
Since  it  is  known  that  GEP100  regulates  the  endocytosis  of  β1-integrin  [107],  Arf6-mediated 
trafficking of β1-integrin may contribute to the acquisition of invasive phenotypes in breast cancer 
cells. Furthermore, recent reports have revealed that oncogenic mutant forms of p53, a major tumor 
suppressor, enhance Rab11-dependent recycling of α5β1-integrin to promote invasive migration [108,109]. 
These observations  strongly suggest  that integrin trafficking is  closely  associated with  cancer  cell 
invasion and metastasis. 
6. Roles of Cell Adhesion Dynamics in Cancer 
6.1. Cancer Metastasis 
Precise regulation of cell adhesion is important for various physiological events, such as normal 
development,  immune  system  and  wound  healing,  and  its  dysregulation  is  associated  with  many 
pathological states, including cancer metastasis. 
The  metastasis  of  carcinomas  consists  of  several  steps  [73,110]  (Figure  5).  (i)  Following  the 
formation of a primary tumor, some tumor cells detach from the primary tumor; (ii) These tumor cells 
invade the basement membranes and local mesenchymal tissues; (iii) They undergo transendothelial 
migration into blood or lymphatic vessels (intravasation); (iv) Escaping from the immune system, they 
survive in the circulation; (v) The cancer cells attach to the vessel wall in the distant organ and migrate 
out of the vessel (extravasation); (vi) They proliferate to establish colonies at the secondary sites. 
These  complicated  processes  require  the  dynamic  regulation  of  cell  adhesions  through  endocytic 
machinery as well as transcriptional regulation. Int. J. Mol. Sci. 2012, 13  4574 
 
 
Figure 5. EMT-mediated invasion and collective invasion in cancer metastasis. Normal 
epithelial cells (orange cells) undergo EMT and form a primary tumor (blue cells). Some 
primary tumor cells invade and migrate into blood circulation as a multicellular strand 
(green  cells).  EMT:  epithelial-mesenchymal  transition,  MAT:  mesenchymal-amoeboid 
transition, MET: mesenchymal-epithelial transition. 
 
6.2. EMT in Cancer 
Several studies pointed out the significance of EMT in cancer invasion [73,111,112], although it 
remains  controversial  because  many  metastatic  tumors  still  retain  epithelial  properties  and 
histopathological similarities to the primary tumors [113,114]. Furthermore, it is also unclear when 
metastasis comes into existence during tumor progression. A classical belief is that the invasion and 
subsequent dissemination of cancer cells occur after primary tumors have considerably expanded and 
have  acquired  high-motility  properties  through  EMT.  However,  recent  accumulating  evidence 
indicates that the metastatic spread of tumor cells is an early step of cancer progression [115,116]. The 
disseminated tumor cells from HER-2 transgenic mammary glands are observed in lymph nodes or 
bone marrow at the premalignant phase, and early-disseminated cancer cells have the competency to 
induce lethal carcinosis [117]. Furthermore, there is no association between the tumor stage of human 
breast cancer and the number of disseminated cells in the bone marrow. 
Regardless of whether it is an early or late event in cancer progression, the invasive migration of 
tumor cells is an initial important step for cancer metastasis. Although EMT has a limited role in 
cancer metastasis, many reports  indicate that complete or incomplete EMT is  associated with  the 
metastasis of tumors, including breast cancer, hepatocellular carcinoma, colorectal cancer, pancreatic Int. J. Mol. Sci. 2012, 13  4575 
 
 
cancer  and  prostate  cancer  [118–124]  (Figure  5).  As  described  above,  EMT  is  accompanied  with 
downregulation  of  E-cadherin  and  upregulation  of  N-cadherin,  the  so-called  ―cadherin  switch‖. 
Transcriptional repression of E-cadherin is mediated by transcriptional repressors, snail family zinc 
finger proteins, Snail (SNAI1) and Slug (SNAI2), ZEB family transcriptional factors, ZEB1 and ZEB2 
(also  known  SIP1),  and  basic  helix-loop-helix  proteins,  Twist1  and  Twist2.  Snail  and  Slug  also 
suppress the transcription of occludin and claudin-1, whereas ZEB2 targets Cx26 and plakophilin-2 [74]. 
TGFβ,  a  major  EMT  inducer,  upregulates  Snail  and  ZEB2  [125–127].  Furthermore,  p12  (also 
known Cdk2ap), a downstream effector of TGFβ, induces EMT through Twist2 upregulation [128].  
In addition to transcriptional regulators, the type II receptor of TGFβ phosphorylates Par6, a polarity 
protein,  and  the  phosphorylated  Par6  recruits  an  E3  ubiquitin  ligase,  Smurf1,  leading  to  the 
degradation  of  RhoA  [129].  Also,  cooperatively  with  Raf-1,  TGFβ  promotes  the  endocytosis  and 
lysosomal degradation of E-cadherin [130]. Therefore, TGFβ signaling is integral in EMT through the 
regulation of transcription, RhoA-dependent cytoskeletal remodeling and endocytosis, even though the 
downstream effect of TGFβ is cell type-specific [114]. 
It has been reported that microRNAs and alternative splicing regulators, ESRP1 and ESRP2, are 
involved  in  tumor  cell  migration  and  EMT  [122,131–135].  A  microRNA,  miR-9  directly  targets  
E-cadherin mRNA, resulting in an increase of cell migration and invasiveness [131,136]. Consistently, 
miR-9 is upregulated in breast cancer cells. In contrast, miR-200 and its related microRNAs, repress 
ZEB1, leading to the inhibition of EMT [122,132,133]. Interestingly, recent studies indicate that EMT 
is associated with the maintenance of stem cell properties, and the miR-200 family suppresses the 
―stemness‖ through the repression of Bmi1, KLF4 as well as ZEB1, suggesting that EMT may induce 
cancer stem cells [122,137–139]. 
6.3. Collective Invasion 
In  several  cancers,  including  melanoma,  breast  cancer  and  colorectal  cancer,  cancer  cells 
collectively  migrate  and  invade  other  tissues  without  incurring  EMT  [113,140–143]  (Figure  5). 
Collective migrating cells form multicellular strands (epithelial sheets) or coherent clusters detached 
from the primary tumors [5]. In either case, their cell-cell and cell-ECM adhesions are maintained, so 
that they can interact with neighboring cells and ECM during migration (Figure 1). In the collective 
migration of L-10 human rectal adenocarcinoma cells, HT-1080 fibroblastoma cells and MDA-MB-231 
breast cancer cells, a leading cell (or a tip cell) in the front expresses MT1-MMP, a membrane-type 
matrix metalloproteinase, while the following cells at the back do not [142,144]. The activity of MT1-MMP 
is required for the transition from individual to collective cell invasion. Furthermore, in the co-cultures 
of  carcinoma  cells  and  stromal  fibroblasts,  the  leading  fibroblasts  invade  in  an  MMP-dependent 
manner and form tracks through α5-integrin-mediated RhoA activation and subsequent activation of 
myosin  light  chain  (MLC),  whereas  carcinoma  cells  follow  the  tracks  generated  by  the  leading 
fibroblasts via Cdc42-mediated regulation of MLC [145]. These findings suggest that during collective 
cell migration, the leading and the following cells exhibit different properties and that the multicellular 
coordination of cell polarity and cytoskeletal regulation has important roles. 
At the cell-cell adhesions in collective migrating cells, actomyosin contractility is kept at low levels 
to maintain cell-cell cohesion [146,147]. Discoidin domain receptor 1 (DDR1) interacts with polarity Int. J. Mol. Sci. 2012, 13  4576 
 
 
proteins, Par3 and Par6, which suppress Rho kinase/ROCK-mediated actomyosin contractility through 
the recruitment of RhoE [146]. Furthermore, DDR1 induces the upregulation of N-cadherin [148], and 
in collective migrating neural crest cells, N-cadherin inhibits membrane protrusion and Rac1 activity at 
cell-cell contacts [149,150]. Thus, cell adhesion molecules not only maintain cell-cell and cell-ECM 
contacts but also regulate intracellular signals to control collective cell migration. 
Interestingly, a recent report has indicated the cooperative roles of EMT-mediated mesenchymal 
cells (EMT-cancer cells) and collective invading cells (non-EMT-cancer cells) [151,152]. EMT-cancer 
cells, but not non-EMT cancer cells, can invade and intravasate into the blood vessels, although they 
cannot establish metastasis in the distal organs. On the other hand, non-EMT-cancer cells can survive 
in the circulation and form the secondary tumors only if they are injected into the blood vessels, but 
not below the skin. When both EMT- and non-EMT cancer cells are inoculated subcutaneously, EMT 
cancer cells are located at the invasive front and the following non-EMT cancer cells can intravasate 
into  the  blood  circulation.  Furthermore,  non-EMT  cells  extravasate  and  establish  metastasis,  
suggesting  that  completing  the  entire  metastatic  process  requires  the  cooperation  between  EMT-  and  
non-EMT-cancer cells. 
6.4. Amoeboid Migration 
While TGFβ regulates the switch from collective to individual migration of breast cancer cells in a 
Smad-dependent  manner  [143],  suppression  of  integrin  causes  the  transition  from  collective  to 
amoeboid migration. Amoeboid cell migration is independent of ECM attachment and protease activity; 
it requires actin cytoskeletal regulation to move forward [153] (Figures 1,5). It has been reported that 
the suppression of cofilin, an actin-binding protein, leads to the transition from amoeboid tumor cells 
to mesenchyme-like cells [154]. p27
kip1, a cyclin-dependent kinase inhibitor protein that negatively 
regulates cell cycle progression, has also been reported to control mesenchymal-amoeboid transition 
(MAT) [155]. Interestingly, p27
kip1 promotes cofilin-mediated actin reorganization as a downstream 
pathway of cyclin-dependent kinase 5 (Cdk5) in neurons [156]. Since Cdk5-mediated regulation of 
p27
kip1  is  associated  with  several  cancers  [157,158],  a  Cdk5-p27
kip1  pathway  might  determine  an 
amoeboid morphology through the regulation of cofilin in cancer. 
7. Endocytic Regulation of Cell Adhesion in Neural Development 
7.1. Cell Adhesion and Cerebral Cortical Development 
Neural tissues, including cerebral cortex, are constructed from an epithelium-derived neural tube [159]. 
In  the  developing  cerebral  cortex,  neural  progenitors  comprise  a  pseudostratified  neuroepithelium  
(or ventricular zone), in which E- and N-cadherin-mediated adherens junctions and gap junctions, but 
not desmosomes, are observed [160–162]. ZO-1 is also localized at the apical parts of neuroepithelium, 
but tight junction structures are not observed after neural tube closure [161]. In the neuroepithelium, 
N-cadherin  is  transported  by  KIF3-mediated  microtubule  plus-end-directed  motor  complexes, 
composed of KIF3A, KIF3B and KAP3 [163], and knockout of N-cadherin or KAP3 results in the 
disruption of neuroepithelial structures [163,164]. Furthermore, N-cadherin-mediated adherens junctions Int. J. Mol. Sci. 2012, 13  4577 
 
 
may  play  an  important  role  in  proper  neuronal  differentiation  because  suppression  of  N-cadherin 
causes premature neuronal differentiation [165]. 
Differentiated  immature  neurons,  generated  from  neural  progenitors,  migrate  out  of  the 
neuroepithelium.  These  migrating  immature  neurons  exhibit  various  morphological  changes,  and 
subsequently attach to radial glial fibers, pia-directed long processes derived from neural progenitors, 
in the developing cerebral cortex [6] (Figure 6). The morphological changes at the early phase of 
migration require the proper regulation of microtubule dynamics and actin cytoskeletal reorganization, 
mediated  by  Rac1-JNK-MAP1B  and  Cdk5-p27
kip1-cofilin  pathways,  respectively  [156,166–168]. 
Since p27
kip1 controls the G1 length of neural progenitors and cell cycle exit through the inhibition of 
CDK activities [169,170], p27
kip1 has dual functions in neural progenitors and migrating neurons, and 
therefore  provides  a  molecular  link  between  the  cell  cycle  exit  and  migration  start.  Interestingly, 
mutations  in  ArfGEF2/Big2  cause  periventricular  heterotopia  (caused  by  the  migration  defect  in 
neurons)  and  microcephaly  (caused  by  the  proliferation  defect  in  neural  progenitors)  in  humans, 
suggesting that ArfGEF2/Big2 and its downstream Arf family small GTPases are also involved in both 
neural  progenitor  proliferation  and  migration  start,  likely  through  the  regulation  of  membrane 
trafficking [171]. 
7.2. Scaffold Cell-Dependent Migration in Neural Development 
After complex morphological changes, immature neurons begin a long-distance migration along 
radial glial fibers, called the locomotion mode of neuronal migration [172], which covers most of the 
neuronal migration route and is therefore a main contributor to neuronal migration and cortical layer 
formation [173]. This migration is a typical example of a scaffold cell-dependent migration (Figure 1). 
N-cadherin is required for the attachment of the locomoting neurons to the radial glial fibers [7,174] 
(Figure 6). A portion of this N-cadherin is internalized by a Rab5-dependent endocytosis and recycled 
to  the  plasma  membrane  via  a  Rab11-dependent  indirect  recycling  pathway,  suggesting  that  the 
intracellular trafficking of N-cadherin is essential for neuronal migration along radial glial fibers [7,52]. 
Although Rab5 is involved in not only clathrin-mediated endocytosis but also some caveolin-mediated 
endocytosis, it is known that at least clathrin function is required for cortical neuronal migration [175]. 
Recent  reports reveal  that a small GTPase, Rap1, regulates N-cadherin  in  migrating neurons as a 
downstream pathway of Reelin, whose mutation in mice results in the disruption of cortical layer 
structures, probably due to the neuronal migration defect [176,177]. In addition, Cx43 and Cx26, gap 
junction components are reported to regulate neuronal adhesion to radial glial fibers [178–180]. On the 
other hand, several  reports indicate that β1-integrin is  less important  for the locomotion mode of 
migration [181,182], suggesting that a scaffold cell-dependent migration largely depends on cell-cell 
adhesions, but not cell-ECM adhesions (Figure 1). Int. J. Mol. Sci. 2012, 13  4578 
 
 
Figure  6.  A  scaffold  cell-dependent  migration  in  neural  development.  The  migrating 
neurons  in  the  developing  cerebral  cortex  show  radial  glial  fiber-dependent  migration, 
which  requires  the  endocytic  trafficking  of  N-cadherin.  EE:  early  endosomes,  
RE: recycling endosomes. 
 
Similar  to  the  developing  cerebral  cortex  in  mice,  N-cadherin  is  required  for  the  migration  of 
cerebellar granule neurons in zebrafish. This, however, is not a scaffold cell-dependent migration but a 
chain migration, an atypical mode of collective migration, which forms cell-cell contacts between 
migrating  neurons  [183].  In  mice,  cerebellar  granule  neurons  exhibit  a  scaffold  cell-dependent 
migration at the late phase of neuronal migration, and forms ―interstitial junctions‖ and desmosome-like 
adhesions with Bergmann glial fibers [184]. A major component of interstitial junctions is astrotactin 
(ASTN1) [185]. Astrotactin is transported during neuronal migration and the trafficking is regulated by 
ASTN2 [186]. Thus, a scaffold cell-dependent migration requires the intracellular trafficking of cell-cell 
adhesion molecules, such as astrotactin and N-cadherin. 
8. Conclusion Remarks 
In physiological  and pathological  conditions,  cell migration plays various  important  roles.  Cell 
migration patterns are classified according to the cell adhesion properties (Figure 1). EMT-mediated 
single cell migration, amoeboid migration, collective migration and scaffold cell-dependent migration 
are differentially used during normal development and regeneration, suggesting that proper regulation 
of cell adhesion in migration is essential for tissue organization and maintenance. It is consistent with 
the fact that abnormal EMT and/or collective migration are closely associated with cancer metastasis. 
As described above, recent studies have uncovered the fact that endocytic trafficking is essentially 
required for several types of cell migration. However, research into the in vivo roles of endocytosis and Int. J. Mol. Sci. 2012, 13  4579 
 
 
intracellular  membrane  trafficking  is  just  beginning.  Better  understanding  of  the  regulatory 
mechanisms of membrane trafficking may uncover yet unknown critical roles in various biological 
fields, including developmental biology, neuroscience and cancer therapy. 
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